Company / Return on Equity (ROE)
Beta Bionics, Inc. Return on Equity (ROE) History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-25.4%
FY2025
5-year range
-25.4% / -25.4%
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#122 of 148
Health Care
What the data says
Beta Bionics, Inc.'s return on equity (roe) of -25.4% is lower than 82% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-25.4% in FY2025.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 148This company -25.4% Sector average -3.2%
▼
-705.8% below sector average
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -25.4% | - |
| FY2024 | - | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026